CD8A and neoplasm: Patients with increased amounts of tumor infiltrating CD8+ cells have been shown to have longer overall survival and disease free survival27–29 and it is believed that high levels of tumor infiltrating T cells may be a significant contributor to the more robust response to immunotherapy seen in tumors with deficient mismatch repair4.